Lpl Financial LLC Catalyst Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

$246 Billion
Q1 2025

A detailed history of Lpl Financial LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 74,229 shares of CPRX stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,229

Previous 57,983 28.02%

Holding current value

$1.59 Million

Previous $1.21 Million 48.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$19.53 - $25.74 $317,284 - $418,172	16,246 Added 28.02%	74,229 $1.8 Million
Q4 2024 Feb 11, 2025	BUY	$19.73 - $23.93 $314,910 - $381,946	15,961 Added 37.98%	57,983 $1.21 Million
Q3 2024 Nov 08, 2024	BUY	$15.19 - $21.35 $38,856 - $54,613	2,558 Added 6.48%	42,022 $835,000
Q2 2024 Aug 07, 2024	SELL	$14.68 - $16.92 $324,031 - $373,475	-22,073 Reduced 35.87%	39,464 $611,000
Q1 2024 May 10, 2024	SELL	$13.18 - $17.11 $118,435 - $153,750	-8,986 Reduced 12.74%	61,537 $980,000
Q4 2023 Feb 14, 2024	SELL	$11.78 - $17.29 $184,345 - $270,571	-15,649 Reduced 18.16%	70,523 $1.19 Million
Q3 2023 Nov 13, 2023	BUY	$11.69 - $15.02 $611,316 - $785,455	52,294 Added 154.36%	86,172 $1.01 Million
Q2 2023 Jul 31, 2023	SELL	$11.5 - $18.08 $383,341 - $602,678	-33,334 Reduced 49.6%	33,878 $455,000
Q1 2023 May 10, 2023	BUY	$14.34 - $21.05 $210,023 - $308,298	14,646 Added 27.86%	67,212 $1.11 Million
Q4 2022 Feb 07, 2023	BUY	$12.25 - $19.5 $344,947 - $549,100	28,159 Added 115.37%	52,566 $977,000
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $10,102 - $22,209	1,431 Added 6.23%	24,407 $313,000
Q2 2022 Aug 12, 2022	BUY	$6.23 - $8.57 $26,228 - $36,079	4,210 Added 22.43%	22,976 $161,000
Q1 2022 May 16, 2022	BUY	$5.31 - $8.31 $16,609 - $25,993	3,128 Added 20.0%	18,766 $156,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $23,106 - $33,040	-4,435 Reduced 22.09%	15,638 $106,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $97,354 - $121,240	20,073 New	20,073 $106,000
Q4 2020 Feb 12, 2021	SELL	$2.97 - $3.83 $29,700 - $38,300	-10,000 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$2.97 - $5.08 $29,700 - $50,800	10,000 New	10,000 $30,000

Others Institutions Holding CPRX

# of Institutions

390

Shares Held

99.9M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.21B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Catalyst Pharmaceuticals, Inc. Transaction History